ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

TGen At Scottsdale Opens Clinical Trial Of OSI-906 For Adrenocortical Carcinoma

September 25, 2009

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012